Literature DB >> 20484424

Reference ranges for LVEF and LV volumes from electrocardiographically gated 82Rb cardiac PET/CT using commercially available software.

Paco E Bravo1, David Chien, Mehrbod Javadi, Jennifer Merrill, Frank M Bengel.   

Abstract

UNLABELLED: Electrocardiographic gating is increasingly used for (82)Rb cardiac PET/CT, but reference ranges for global functional parameters are not well defined. We sought to establish reference values for left ventricular ejection fraction (LVEF), end systolic volume (ESV), and end diastolic volume (EDV) using 4 different commercial software packages. Additionally, we compared 2 different approaches for the definition of a healthy individual.
METHODS: Sixty-two subjects (mean age +/- SD, 49 +/- 9 y; 85% women; mean body mass index +/- SD, 34 +/- 10 kg/m(2)) who underwent (82)Rb-gated myocardial perfusion PET/CT were evaluated. All subjects had normal myocardial perfusion and no history of coronary artery disease (CAD) or cardiomyopathy. Subgroup 1 consisted of 34 individuals with low pretest probability of CAD (<10%), and subgroup 2 comprised 28 subjects who had no atherosclerosis on a coronary CT angiogram obtained concurrently during the PET/CT session. LVEF, ESV, and EDV were calculated at rest and during dipyridamole-induced stress, using CardIQ Physio (a dedicated PET software) and the 3 major SPECT software packages (Emory Cardiac Toolbox, Quantitative Gated SPECT, and 4DM-SPECT).
RESULTS: Mean LVEF was significantly different among all 4 software packages. LVEF was most comparable between CardIQ Physio (62% +/- 6% and 54% +/- 7% at stress and rest, respectively) and 4DM-SPECT (64% +/- 7% and 56% +/- 8%, respectively), whereas Emory Cardiac Toolbox yielded higher values (71% +/- 6% and 65% +/- 6%, respectively, P < 0.001) and Quantitated Gated SPECT lower values (56% +/- 8% and 50% +/- 8%, respectively, P < 0.001). Subgroup 1 (low likelihood) demonstrated higher LVEF values than did subgroup 2 (normal CT angiography findings), using all software packages (P < 0.05). However, mean ESV and EDV at stress and rest were comparable between both subgroups (p = NS). Intra- and interobserver agreement were excellent for all methods.
CONCLUSION: The reference range of LVEF and LV volumes from gated (82)Rb PET/CT varies significantly among available software programs and therefore cannot be used interchangeably. LVEF results were higher when healthy subjects were defined by a low pretest probability of CAD than by normal CT angiography results.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484424     DOI: 10.2967/jnumed.109.073858

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  13 in total

1.  ⁸²Rb PET myocardial perfusion imaging is superior to ⁹⁹mTc-labelled agent SPECT in patients with known or suspected coronary artery disease.

Authors:  Albert Flotats; Paco E Bravo; Kenji Fukushima; Muhammad A Chaudhry; Jennifer Merrill; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-05-31       Impact factor: 9.236

2.  Interpreting the change in left ventricular ejection fraction during pharmacological coronary vasodilation: Proceed with caution!

Authors:  Steven Port
Journal:  J Nucl Cardiol       Date:  2017-03-07       Impact factor: 5.952

3.  Automated quantitative Rb-82 3D PET/CT myocardial perfusion imaging: normal limits and correlation with invasive coronary angiography.

Authors:  Ryo Nakazato; Daniel S Berman; Damini Dey; Ludovic Le Meunier; Sean W Hayes; Jimmy S Fermin; Victor Y Cheng; Louise E J Thomson; John D Friedman; Guido Germano; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2011-12-28       Impact factor: 5.952

4.  Comparison of the myocardial blood flow response to regadenoson and dipyridamole: a quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET.

Authors:  Behnaz Goudarzi; Kenji Fukushima; Paco Bravo; Jennifer Merrill; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-09       Impact factor: 9.236

Review 5.  Clinical use of cardiac PET/MRI: current state-of-the-art and potential future applications.

Authors:  Patrick Krumm; Stefanie Mangold; Sergios Gatidis; Konstantin Nikolaou; Felix Nensa; Fabian Bamberg; Christian la Fougère
Journal:  Jpn J Radiol       Date:  2018-03-10       Impact factor: 2.374

Review 6.  Cardiac PET perfusion: prognosis, risk stratification, and clinical management.

Authors:  Sharmila Dorbala; Marcelo F Di Carli
Journal:  Semin Nucl Med       Date:  2014-09       Impact factor: 4.446

7.  Calculation of left ventricular volumes and ejection fraction from dynamic cardiac-gated 15O-water PET/CT: 5D-PET.

Authors:  Jonny Nordström; Tanja Kero; Hendrik Johannes Harms; Charles Widström; Frank A Flachskampf; Jens Sörensen; Mark Lubberink
Journal:  EJNMMI Phys       Date:  2017-11-14

8.  Diagnostic Performance of PET Versus SPECT Myocardial Perfusion Imaging in Patients with Smaller Left Ventricles: A Substudy of the 18F-Flurpiridaz Phase III Clinical Trial.

Authors:  René R Sevag Packard; Joel L Lazewatsky; Cesare Orlandi; Jamshid Maddahi
Journal:  J Nucl Med       Date:  2020-11-27       Impact factor: 10.057

9.  Automatic extraction of forward stroke volume using dynamic PET/CT: a dual-tracer and dual-scanner validation in patients with heart valve disease.

Authors:  Hendrik Johannes Harms; Lars Poulsen Tolbod; Nils Henrik Stubkjær Hansson; Tanja Kero; Lovisa Holm Orndahl; Won Yong Kim; Tomas Bjerner; Kirsten Bouchelouche; Henrik Wiggers; Jørgen Frøkiær; Jens Sörensen
Journal:  EJNMMI Phys       Date:  2015-10-26

10.  Normal Myocardial Flow Reserve in HIV-Infected Patients on Stable Antiretroviral Therapy: A Cross-Sectional Study Using Rubidium-82 PET/CT.

Authors:  Andreas Knudsen; Thomas E Christensen; Adam Ali Ghotbi; Philip Hasbak; Anne-Mette Lebech; Andreas Kjær; Rasmus Sejersten Ripa
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.